These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27453970)

  • 1. CardioPulse. Catheter-based renal denervation for hypertension treatment: update 2015.
    Ewen S; Zivanovic I; Böhm M; Mahfoud F
    Eur Heart J; 2016 Mar; 37(12):930-3. PubMed ID: 27453970
    [No Abstract]   [Full Text] [Related]  

  • 2. Ambulatory blood pressure may be designed as the primary efficacy outcome in clinical trials on renal denervation.
    Wang Y
    Int J Cardiol; 2014 Oct; 176(3):1262-3. PubMed ID: 25115259
    [No Abstract]   [Full Text] [Related]  

  • 3. Catheter-based renal denervation: Back on track?
    Lauder L; Ewen S; Böhm M; Mahfoud F
    Eur Heart J; 2018 Dec; 39(46):4058-4059. PubMed ID: 30535015
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal Denervation: History and Current Status.
    Lee DP
    Interv Cardiol Clin; 2020 Oct; 9(4):483-488. PubMed ID: 32921372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous renal denervation: new treatment option for resistant hypertension and more?
    Ewen S; Ukena C; Böhm M; Mahfoud F
    Heart; 2013 Aug; 99(15):1129-34. PubMed ID: 23418204
    [No Abstract]   [Full Text] [Related]  

  • 6. Catheter-based renal denervation: the next chapter begins.
    Mahfoud F; Schlaich M; Böhm M; Esler M; Lüscher TF
    Eur Heart J; 2018 Dec; 39(47):4144-4149. PubMed ID: 30239686
    [No Abstract]   [Full Text] [Related]  

  • 7. [Catheter-based renal denervation: a new method for resistant hypertension. Initial experiences of the procedure shows significant decrease in blood pressure].
    Rundqvist B; Völz S; Manhem K; Herlitz H; Haraldsson I; Andersson B
    Lakartidningen; 2013 Jan 16-22; 110(3):86-8. PubMed ID: 23424985
    [No Abstract]   [Full Text] [Related]  

  • 8. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal nerve ablation for hypertension: Update from an insider.
    Esler M
    Eur Heart J; 2018 Dec; 39(46):4054-4055. PubMed ID: 30535014
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal sympathetic denervation: Recalculating….
    Belardi JA; Albertal M
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):795-796. PubMed ID: 27865077
    [No Abstract]   [Full Text] [Related]  

  • 11. It is urgent to investigate predictors of the response of blood pressure to renal denervation.
    Wang Y
    Can J Cardiol; 2014 Apr; 30(4):465.e7. PubMed ID: 24561011
    [No Abstract]   [Full Text] [Related]  

  • 12. [Renal sympathetic denervation in refractory hypertension].
    Sans Atxer L; Oliveras A
    Med Clin (Barc); 2013 Mar; 140(6):263-5. PubMed ID: 23276614
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of arterial hypertension: from no treatment to renal denervation.
    Stefanadis CI
    Hellenic J Cardiol; 2015; 56(3):277-8. PubMed ID: 26021256
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence.
    Persu A; Renkin J; Asayama K; O'Brien E; Staessen JA
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):739-49. PubMed ID: 23750683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Catheter-based renal sympathetic denervation for the treatment of resistant arterial hypertension in Poland - experts consensus statement].
    Witkowski A; Januszewicz A; Imiela J; Narkiewicz K; Opolski G; Rowiński O; Sadowski J; Dudek D; Bryniarski L; Gil RJ; Adamczak M; Grajek S; Kądziela J; Prejbisz A; Nowicki M
    Kardiol Pol; 2011; 69(11):1208-11. PubMed ID: 22090243
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal artery stenosis may be responsible for the gradual return of high blood pressure after renal denervation.
    Wang Y
    J Clin Hypertens (Greenwich); 2014 Apr; 16(4):313. PubMed ID: 24612084
    [No Abstract]   [Full Text] [Related]  

  • 17. Device-Directed Therapy for Resistant Hypertension.
    Tankut SS; Yoruk A; Bisognano JD
    Cardiol Clin; 2017 May; 35(2):255-260. PubMed ID: 28411899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: renal sympathetic denervation: a true lack of efficacy, or the victim of a "perfect storm"?
    Baker NC; Waksman R
    Cardiovasc Revasc Med; 2014 Mar; 15(2):61-2. PubMed ID: 24684755
    [No Abstract]   [Full Text] [Related]  

  • 19. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence.
    Hiremath S; Froeschl M; Ruzicka M
    Curr Opin Cardiol; 2014 Jul; 29(4):336-43. PubMed ID: 24859619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to letter to the editor: "Renal artery stenosis may be responsible for the gradual return of high blood pressure after renal denervation".
    Papademetriou V
    J Clin Hypertens (Greenwich); 2014 Apr; 16(4):314. PubMed ID: 24612114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.